Search Icon
Asst. Prof. MD. Ece Vural

Asst. Prof. MD.

Ece Vural

Liv Hospital Ankara
Hematology
Single Form Doctors

Asst. Prof. MD.

Ece Vural

Liv Hospital Ankara
Hematology
Single Form Doctors

Areas of Interests

  • Multiple Myeloma
  • Lymphoma
  • Bone marrow transplant
1

h-index

Education:
  • Akdeniz University Faculty of Medicine Hematology Specialization (2019-2023)
  • Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Internal Medicine Specialization (2014-2019)
  • Istanbul University, Cerrahpaşa Faculty of Medicine, Medical Education (2008-2014)
  • Vefa High School (2003-2007)
Experience:
  • Yüksek İhtisas University, Liv Hospital Ankara (2024- )
  • Sivas Numune Hospital (2023-2024)
  • Siirt Pervari State Hospital

• Vural, E., Elverdi, T., Salihoğlu, A., Ar, M. C., Öngören, ş., Başlar, Z., … & Eşkazan, A. E. Complications of therapeutic plasma exchange: A retrospective, single”center study of 2505 procedures performed in 338 patients over 15 years. Therapeutic Apheresis and Dialysis 2024. Science Citation Index Expanded (SCIE), Q3.
• Yucel, O. K., Vural, E., Alhan, N., Vurgun, S., Atas, U., Yapar, D., … & Undar, L. (2023). Lower Body Mass Index and Prognostic Nutritional Index Are Associated with Poor Posttransplant Outcomes in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. Oncology, 101(11), 753-764. Science Citation Index Expanded, Q2
• ILTAR, U., Vural, E. C. E., ALHAN, F. N., Vurgun, S. E. R. T. A. Ç., ATAS, U., YUCEL, O. K., … & Undar, L. E. V. E. N. T. (2023). Real-Life Experience of Dose-Adjusted Venetoclax in Acute Myeloid Leukemia Patients Concomitantly Using Posaconazole for Antifungal Prophylaxis: A Single-Center Experience. UHOD: International Journal of Hematology & Oncology, 33(2). Science Citation Index Expanded, Q4
• Iltar, U., Alhan, F. N., Vural, E., Ataş, Ü., Sözel, H., Doğan, Ö., … & Ündar, L. (2022). Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome. Journal of Onco”logy Pharmacy Practice, 28(2), 500-503. Science Citation Index Expanded, Q3
• ILTAR, U., ÜNDAR, L., SALİM, O., YÜCEL, O. K., ALHAN, F. N., VURAL, E., … & DEVECİ, B. (2022). Clinical and Survival Outcomes in Patients with Supra-Diaphragmatic Vs Infra-Diaphragmatic Diffuse Large B Cell Lymphoma. Osmangazi Medical Journal, 44(5), 605-612.TR index.
• ILTAR, U., SALIM, O., Unal, A. T. A. S., VURAL, E., ALHAN, F. N., YUCEL, O. K., … & UNDAR, L. Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real -Life Multicenter Experience on Off-Label Use of Ibrutinib. International Journal of Hematology and Oncology, 33(4), 191-197. Science Citation Index Expanded, Q4
• Iltar, U., Ataş, Ü., Vural, E., Alhan, F. N., Yücel, O. K., Salim, O., & Undar, L. (2022). Outcomes of stem cell mobilization and engraftment in patients with multiple myeloma according to CD56 expression status. Transfusion and Apheresis Science, 61(3), 103351. Science Citation Index Expanded, Q3
• Ogut, T. S., Vural, E., Aslan, B., Dilbil, M., Erbasan, F., & Terzioglu, M. E. (2021). Hemolytic anemia related to cold agglutinin in a patient with systemic lupus erythematosus/Cold agglutinin-related hemolytic anemia in a patient with systemic lupus erythematosus. Journal of Turkish Society for Rheumatology, 13(3), 137-140. TR index
• Atas, U., Vural, E., Iltar, U., Yucel, O., Salim, O., & Undar, L. (2020). Polatuzumab based chemoimmunotherapy showing complete response in a patient of r/r diffuse large b-cell lymphoma. Hematology, Transfusion and Cell Therapy, 42, 51. Emerging Sources Citation Index, Q3
• Cerme, E., Seven, S., Vural, E., Mercan, S., & Bavunoglu, I. (2020). A case with unexplained weight loss the underlying cause is aluminum toxicity. Medicine, 9(3), 790-2. TR index
• Yılmaz, Y., Vural, E., Toprak, D. E., Gürdeniz, E., Dede, E., Oba, M. Ç., … & Emül, M. (2014). The relationship between medical education and eating habits along with mental condition in medical students. Erciyes Medical Journal/Erciyes Medical Journal, 36(2). Scopus.
• A Case of Acute Lymphoblastic Lymphoma with Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation (13th National Bone Marrow Transplantation and Cellular Therapies Congress (Online), Antalya, Turkey, April 2 – 03, 2021, pp.156-157)
• Factor 5 Leiden Mutation Thrombotic Thrombocytopenic Purpura: A Case Report (9th Aegean Hematology Oncology Congress (Online), Izmir, Turkey, 18 – 20 March 2021, p.92).
• Use of Azacitidine and Venetoclax Combination in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia Patients; Single Center Experience. (9th Aegean Hematology Oncology Congress (Online), Izmir, Turkey, March 18 – 20, 2021, p.36)
• Use of Micafungin in Primary Prophylaxis with Induction Therapy in Acute Lymphoblastic Lymphoma; Single Center Experience. (9th Aegean Hematology Oncology Congress ( Online), Izmir, Turkey, March 18 – 20, 2021, pp.27)
• Dealing with Complications Developing with Acquired Hemophilia Treatment; Case Report. (7th Hemophilia Case Education Symposium, (Online), Antalya, Turkey, February 18 – 20 2021, pp.30-31)
• IgD Multiple Myeloma Presenting with Myelomatous Pleural Effusion: An Unusual Presentation of a Rare Case. (3rd Hematological Rare Diseases Congress (Online), Antalya, Turkey, December 25 – 27, 2020, pp.63-64)
• Effectiveness of Venatoclax Monotherapy in Relapsed Chronic Lymphocytic Leukemia Case. (Hematology Specialist Association National Congress 2020 (Online), Antalya, Turkey, December 12 – 15, 2020, pp.27-28)
• A Case of Splenic Marginal Zone Lymphoma Unresponsive to Rituximab. (Hematology Specialist Association National Congress 2020 (Online), Antalya, Turkey, December 12 – 15, 2020, pp.11-12).
•Extramedullary Myeloma Case Presenting with a Giant Intraabdominal Mass (46th National Hematology Congress (Online), Antalya, Turkey, October 28 – 31, 2020, pp.134-135).
• Effect of New Generation Anti-Myeloma Agents on Overall Survival in Primary Plasma Cell Leukemia Patients; Single Center Experience with Cases. (46th National Hematology Congress (Online), Antalya, Turkey, October 28 – 31, 2020, pp.109-110).
• Treatment of Low-Grade Non-Hodgkin Lymphoma Involving the Kidney with Ibrutinib. (46th National Hematology Congress (Online), Antalya, Turkey, October 28 – 31, 2020, pp.188).
• Congestive Heart Failure Due to Bortezomib and Cyclophosphamide Administration in a Patient with Multiple Myeloma. (46th National Hematology Congress (Online), Antalya, Turkey, October 28 – 31, 2020, pp. 215).
• Polatuzumab Based Chemoimmunotherapy Showing Complete Response in a Patient of R/R Diffuse Large B-Cell Lymphoma. (11th International Eurasian Hematology Oncology Congress (Online), Antalya, Turkey, October 21 – 24, 2020, pp. 51).
• Involvement of Central Nervous System with Invasive Fungal Infection Caused by Saprochaete Clavata in a Patient with Acute Lymphoblastic Leukemia. (7th Aegean Hematology Oncology Symposium (Online), Antalya, Turkey, September 17 – 19, 2020, pp. 25).
• Hemolytic Anemia Developing After Liver Transplantation: Passenger Lymphocyte Syndrome. (6th Aegean Hematology Oncology Congress, Izmir, Turkey, March 13-15, 2020, p.36).
• Results of the Turkish Hereditary Thrombotic Thrombocytopenic Purpura Registry System (49th National Hematology Congress, Antalya November 1-5, p:38)
• Cold Agglutinin Disease (49th National Hematology Congress, Antalya November 1-5, p:11).
• Neutropenia Developing After Abvd Chemotherapy in Hodgkin Lymphoma Patients and Its Relationship with Survival (49th National Hematology Congress, Antalya November 1-5, p:115).
• Evaluation of Post-Transplantation Periods of Patients Mobilized with Plerixafor; Single Center Experience (48th National Hematology Congress, Antalya 1-5 November, pp:69).
• Among Nutritional Parameters, Body Mass Index is the Only Factor Affecting Transplant Outcomes in Autologous Transplanted Lymphoma Patients. (48th National Hematology Congress, Antalya 1-5 November, pp:10).
• A Very Rare Case: Adult B-All Case Presenting with Multiple Osteolytic Bone Lesions (48th National Hematology Congress, Antalya 1-5 November, pp:151).
• 4-Day Granulocyte Colony Stimulating Factor Application Provides Sufficient Stem Cell Mobilization in Healthy Donors, Single Center Experience (48th National Hematology Congress, Antalya 1-5 November, pp:238).
• Complications Developing Due to Therapeutic Plasma Exchange Applications: Single Center Experience (45th National Hematology Congress, Antalya October 30-November 02, 2019, pp:19).
• Colitis Associated with Dasatinib (44th National Hematology Congress, Antalya October 31-November 03, 2018, pp:51).
• Chronic Myeloid Leukemia Case with Hyperbilirubinemia Under Nilotinib Treatment (43rd National Hematology Congress, Antalya November 1-4, 2017, pp:163).
• Evaluation of Nine Cases with Hypofibrinogenemia; Single Center Experience (42nd National Hematology Congress, Antalya October 19-22, 2016, pp:22).
• Vural, E., Ozunal, I. E., Salihoglu, A., Yurttas, N. O., Keskin, D., Sadri, S., … & Baslar, Z. (2016, May). HYPOFIBRINOGENEMIA; DESCRIPTIVE REPORT OF 5 CASES, SINGLE CENTRE EXPERIENCE. In THROMBOSIS RESEARCH (Vol. 141, pp. S63-S63). THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND: PERGAMON-ELSEVIER SCIENCE LTD
• Ece Vural, Muhlis Cem Ar, Antibodies, Immunology for Hematologists, Galenos Publishing House, Istanbul, 2016;10-16.
• Ece Vural, Ozan Salim, Vaccination in Adult Hematological Diseases, Supportive Treatments in Hematology (Hematologist), Ankara, 2020; 1-9.
• Ece Vural, Orhan Kemal Yücel; Blood Transfusion in Thalassemia, Erdal Kurtoğlu editor. Blood Banking Problems and Solutions, Turkey Clinics 1st Edition, Ankara 2022.
• Ece Vural, Heparin-Induced Thrombocytopenia, THNG Hematology Handbook, 1st Edition, Chapter 88, Istanbul 2023
• Hoffbrand General Overview of Hematology, Erythropoiesis and Anemia (Chapter 2), Ahmet Emre Eşkazan ed. 8th Edition, Istanbul Medical Bookstore, Istanbul; 2023 12-25. (Translation)
• Hoffbrand Hematology, Platelets, blood coagulation and hemostasis (Chapter 24), Ahmet Emre Eşkazan ed. 8th Edition, Istanbul Medical Bookstore, Istanbul 2023; 297-311. (Translation)
• Lena M. Napolitano Hematologic Advances in Trauma Resuscitation, Hematologic Challenges in the Critically Ill, , Springer, 2018; 103-125. (Translation).

  • Turkish Hematology Association (2021-still).
  • European Hematology Association (2021-still).
  • Hematology Medical Specialization Qualification Commission (HEMTUYEK) (2022-still; 2022-2023 Medical Specialization Students Working Group President).
  • Vefa Graduates Association (2007-still).
Courses Attended:
  • AKA-Medika Medical statistics 1 (2023), 2 (2024)
  • European Hematology Association Master Class (2022-2023)
  • Turkish Blood Science Lymphoma Academy (2022-2023)
  • Hematology Oncology Clinical Research Basic Education (THD, 2021)
  • Advanced Good Clinical Practice Education (THD, 2021)
Certificates:
  • HEMTUYEK qualification certificate (2024)
  • YÖKDİL-English Health Sciences: 95 points (2023)
  • AKA-Medika Medical statistics 1 (2023), 2 (2024)
  • European Hematology Association Master Class (2022-2023)
  • Turkish Blood Science Lymphoma Academy (2022-2023)
  • La-Cantera project first place (FOLLOW-7 project, 2023)
  • European Hematology Examination (2022)
  • Hematology Oncology Clinical Research Basic Education (THD, 2021)
  • Advanced Good Clinical Practices Education (THD, 2021)
  • American Hematology Association CME/MOC Test (2021)

Ask Our Experts

Doctors

Subscribe to Liv E-newsletter